Assistant Professor in Medicine-Infectious Diseases, Northwestern University Medical School
Infectious Disease
Dr. Babafemi O. Taiwo, MD
|
|
Give Review
Babafemi Taiwo works in the field of Infectious Disease. Babafemi O. Taiwo is a published doctor. He published 63 publications, including: 'The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United States.' Babafemi Taiwo is registered with Medicare.
Publications
- Suicidal Behavior and Associations with Quality of Life among HIV/AIDS-Infected Patients in Ibadan, Nigeria.
- Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers (BTMs) in HIV/HCV Co-Infected Patients.
- Factors Associated With CD8+ T-Cell Activation in HIV-1-Infected Patients on Long-term Antiretroviral Therapy.
- High Cellular Iron Levels Are Associated with Increased HIV Infection and Replication.
- Comparison of auditory brainstem response in HIV-1 exposed and unexposed newborns and correlation with the maternal viral load and CD4+ cell counts.
- Rifaximin Has a Marginal Impact on Microbial Translocation, T-cell Activation and Inflammation in HIV-Positive Immune Non-responders to Antiretroviral Therapy - ACTG A...
- Early suppressive antiretroviral therapy in HIV infection is associated with measurable changes in the corpus callosum.
- Phylogenetic evidence of HIV-1 sequence evolution in subjects with persistent low-level viremia.
- Significance and clinical management of persistent low level viremia and very low level viremia in HIV-1 infected patients.
- Disposition of amodiaquine and desethylamodiaquine in HIV-infected Nigerian subjects on nevirapine-containing antiretroviral therapy.
- Virologic Response, Early HIV-1 Decay, and Maraviroc Pharmacokinetics With the Nucleos(t)ide-Free Regimen of MaravIroc Plus Darunavir/Ritonavir in a Pilot Study.
- Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial f...
- Factors associated with remaining on initial randomized efavirenz-containing regimens.
- Associations of T cell activation and inflammatory biomarkers with virological response to darunavir/ritonavir plus raltegravir therapy.
- Understanding and controlling chronic immune activation in the HIV-infected patients suppressed on combination antiretroviral therapy.
- Hematologic, Hepatic, Renal and Lipid Laboratory Monitoring Following Initiation of Combination Antiretroviral Therapy in the United States, 2000-2010.
- Evidence for risk-stratification when monitoring for toxicities following initiation of combination antiretroviral therapy.
- CD8+ T-cell Activation in HIV-1-Infected Patients Experiencing Transient Low-level Viremia During Antiretroviral Therapy.
- The Design of Single-Arm Clinical Trials of Combination Antiretroviral Regimens for Treatment-Naive HIV-Infected Patients.
- Transmitted antiretroviral drug resistance in newly HIV-infected and untreated patients in Ségou and Bamako, Mali.
- Accelerated aging and human immunodeficiency virus infection: emerging challenges of growing older in the era of successful antiretroviral therapy.
- More reasons to reexamine the definition of viral blip during antiretroviral therapy.
- Exposure of dentists to Mycobacterium tuberculosis, Ibadan, Nigeria.
- Patient-selected treatment partners did not protect against drug resistance during first-line NNRTI-based HAART in a randomized trial.
- Assessing the viorologic and adherence benefits of patient-selected HIV treatment partners in a resource-limited setting.
- Clinical applications and availability of CD4+ T cell count testing in sub-Saharan Africa.
- Transmitted Resistance: An Overview and Its Potential Relevance to the Management of HIV-Infected Persons in Resource-Limited Settings.
- Darunavir: an overview of an HIV protease inhibitor developed to overcome drug resistance.
- Man with a right thigh mass.
- Cost-effectiveness of screening for HIV.
- Primary human immunodeficiency virus.
- High-risk human papilloma virus and cervical abnormalities in HIV-infected women with normal cervical cytology.
- Psoas abscess: a primer for the internist.
- Temporal Changes in Renal Glomerular Function Associated with the use of Tenofovir Disoproxil Fumarate in HIV-Infected Nigerians.
- Combination nucleoside/nucleotide reverse transcriptase inhibitors for treatment of HIV infection.
- Novel antiretroviral combinations in treatment-experienced patients with HIV infection: rationale and results.
- Nontuberculous mycobacterial lung diseases.
- Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262).
- Clinical outcomes of adolescents and young adults in adult HIV care.
- Antiretroviral Drug Resistance in HIV-1-Infected Patients Experiencing Persistent Low-Level Viremia During First-Line Therapy.
- Unmet therapeutic needs in the new era of combination antiretroviral therapy for HIV-1.
- Predictors of atypical squamous cell of undetermined significance cervical cytology with high-risk human papilloma virus genotypes.
- Suboptimal etravirine activity is common during failure of nevirapine-based combination antiretroviral therapy in a cohort infected with non-B subtype HIV-1.
- Adherence to antiretroviral therapy: the more you look, the more you see.
- Understanding transmitted HIV resistance through the experience in the USA.
- Shigella sonnei bacteremia: two adult cases and review of the literature.
- Can tumor necrosis factor alpha blockade predispose to severe babesiosis?
- Outcomes for therapeutic vaccines trials.
- Mitochondrial function, morphology and metabolic parameters improve after switching from stavudine to a tenofovir-containing regimen.
- Long-term serologic responses to the Pneumocystis jirovecii major surface glycoprotein in HIV-positive individuals with and without P. jirovecii infection.
- Weight and smoking cessation among low-income African Americans.
- Reported cessation advice given to African Americans by health care providers in a community health clinic.
- Use of thalidomide in HIV infection.
- HIV-associated wasting: brief review and discussion of the impact of oxandrolone.
- AIDS-related primary CNS lymphoma: a brief review.
- Nevirapine toxicity.
- Mycobacterium tuberculosis and Mycobacterium africanum in stools from children attending an immunization clinic in Ibadan, Nigeria.
- Antiretroviral treatment: current approach and future prospects.
- Prosthetic valve/conduit infection caused by Cardiobacterium valvarum.
- Higher risk of AIDS or death in patients with lower CD4 cell counts after virally suppressive HAART.
- Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients.
- The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United States.
Schools
University Of Ibadan
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
McGaw Medical Center of Northwestern University -
University of Ibadan
Hospital
-
Northwestern Memorial Hospital
Drug Facts
| NPI NUMBER | 1710052931 | |
| NPPES Provider LastName | TAIWO | |
| NPPES Provider FirstName | BABAFEMI | |
| NPPES Provider ZIPCode | 606112927 | |
| NPPES Provider State | IL | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 1342.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1710052931 |
| Last Name Of The Provider | TAIWO |
| First Name Of The Provider | BABAFEMI |
| View All |
Similar Doctors
|
Dr. Joel B. Spear, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan C. Bleasdale, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. James E. Harley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chad J. Achenbach, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Beverly E. Sha, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aimee C. Hodowanec, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Craig S. Conover, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Prerana J. Roth, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Endale T. Mekonen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Oluwatoyin M. Adeyemi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neringa S. Zadeikis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ulana R. Bodnar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Teresa R. Zembower, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald C. Hershow, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Natasa Loznjakovic Margeta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carol A. Olson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew R. Cha, MD |
|
Dr. Mangala Yeturu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fritzie S. Albarillo, MD |
|
|
Dr. Marcella L. McGuinn, MD
This Doctor is OpenDoctor Recommended.
|